Certified by Founder Lodge
Thielsen Capital
United States - Bend, Oregon
INVESTOR
1 Disclosed Funding Rounds $0
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Thielsen is a seed stage syndicate network which brings together life science investors, operators, and innovators to drive exceptional outcomes for founding teams, investors, and science.
| Company | Date | Round | Raised |
|---|---|---|---|
 Parhelia Biosciences |
October, 18 ,2023 | Series A |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Numeral(US) | $18,000,000 | (Mar 7, 2025)
ctrl+s GmbH | $1,083,350 | (Mar 7, 2025)
hema.to GmbH | $3,900,060 | (Mar 7, 2025)
Lumata Health | $20,000,000 | (Mar 7, 2025)
Uniti AI | $4,000,000 | (Mar 7, 2025)
